F T Cutts

Summary

Affiliation: London School of Hygiene and Tropical Medicine
Country: UK

Publications

  1. ncbi request reprint Measles elimination: progress and challenges
    F T Cutts
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
    Vaccine 17:S47-52. 1999
  2. ncbi request reprint Modelling the incidence of congenital rubella syndrome in developing countries
    F T Cutts
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK
    Int J Epidemiol 28:1176-84. 1999
  3. ncbi request reprint Caution--mortality ratios ahead
    F T Cutts
    Medical Research Council Laboratories, Banjul, Gambia
    Lancet 361:2169-70. 2003
  4. pmc Human papillomavirus and HPV vaccines: a review
    F T Cutts
    Initiative for Vaccine Research, WHO, Geneva, Switzerland
    Bull World Health Organ 85:719-26. 2007
  5. ncbi request reprint The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome
    E Vynnycky
    Infectious Disease Epidemiology Unit, Department of Infectious and Tropical Diseases, Keppel Street, London WC1E 7HT, UK
    Vaccine 21:2708-19. 2003
  6. ncbi request reprint Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000-2004
    W Nigatu
    Ethiopian Health and Nutrition Research Institute EHNRI, Addis Ababa, Ethiopia
    J Med Virol 78:1648-55. 2006
  7. ncbi request reprint Measles trends and vaccine effectiveness in Nairobi, Kenya
    P K Borus
    Centre for Virus Research, Kenya Medical Research Institute, P O Box 54628, Nairobi, Kenya
    East Afr Med J 80:361-4. 2003
  8. ncbi request reprint Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
    F T Cutts
    Medical Research Council Laboratories, Banjul, The Gambia
    Lancet 365:1139-46. 2005
  9. pmc Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control
    A Abebe
    Virology and Rickettsiology Research Team, Ethiopian Health and Nutrition Research Institute EHNRI, Addis Ababa, PO Box 1242, Ethiopia
    Epidemiol Infect 131:757-70. 2003
  10. pmc Principles of measles control
    F T Cutts
    Immunization Division, Centers for Disease Control, Atlanta, GA 30333
    Bull World Health Organ 69:1-7. 1991

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Measles elimination: progress and challenges
    F T Cutts
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
    Vaccine 17:S47-52. 1999
    ....
  2. ncbi request reprint Modelling the incidence of congenital rubella syndrome in developing countries
    F T Cutts
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK
    Int J Epidemiol 28:1176-84. 1999
    ..Data on the burden of congenital rubella syndrome are important to guide rubella vaccination policies...
  3. ncbi request reprint Caution--mortality ratios ahead
    F T Cutts
    Medical Research Council Laboratories, Banjul, Gambia
    Lancet 361:2169-70. 2003
  4. pmc Human papillomavirus and HPV vaccines: a review
    F T Cutts
    Initiative for Vaccine Research, WHO, Geneva, Switzerland
    Bull World Health Organ 85:719-26. 2007
    ..Tiered pricing for HPV vaccines, innovative financing mechanisms and multidisciplinary partnerships will be essential in order for the vaccines to reach populations in greatest need...
  5. ncbi request reprint The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome
    E Vynnycky
    Infectious Disease Epidemiology Unit, Department of Infectious and Tropical Diseases, Keppel Street, London WC1E 7HT, UK
    Vaccine 21:2708-19. 2003
    ..Our findings highlight the need for countries to establish surveillance of trends in susceptibility to rubella and CRS incidence and perhaps introduce rubella vaccination among women of child-bearing age...
  6. ncbi request reprint Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000-2004
    W Nigatu
    Ethiopian Health and Nutrition Research Institute EHNRI, Addis Ababa, Ethiopia
    J Med Virol 78:1648-55. 2006
    ..Refinement of measles control measures might include targeting older age groups (5-14 years) and strengthening routine immunization particularly where importation of cases is a concern...
  7. ncbi request reprint Measles trends and vaccine effectiveness in Nairobi, Kenya
    P K Borus
    Centre for Virus Research, Kenya Medical Research Institute, P O Box 54628, Nairobi, Kenya
    East Afr Med J 80:361-4. 2003
    ..To determine morbidity and mortality from measles and to estimate measles vaccine effectiveness among children hospitalised with measles in two hospitals in Nairobi...
  8. ncbi request reprint Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
    F T Cutts
    Medical Research Council Laboratories, Banjul, The Gambia
    Lancet 365:1139-46. 2005
    ..Pneumonia is estimated to cause 2 million deaths every year in children. Streptococcus pneumoniae is the most important cause of severe pneumonia. We aimed to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children...
  9. pmc Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control
    A Abebe
    Virology and Rickettsiology Research Team, Ethiopian Health and Nutrition Research Institute EHNRI, Addis Ababa, PO Box 1242, Ethiopia
    Epidemiol Infect 131:757-70. 2003
    ..These results should target future research studies of underlying risk factors. Furthermore, we generate a crude estimate of the level of coverage of HBV vaccine that would be required to eliminate the virus from the study population...
  10. pmc Principles of measles control
    F T Cutts
    Immunization Division, Centers for Disease Control, Atlanta, GA 30333
    Bull World Health Organ 69:1-7. 1991
    ....
  11. pmc Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination
    F Enquselassie
    Department of Community Health, Faculty of Medicine, University of Addis Ababa, PO Box 1176, Addis Ababa, Ethiopia
    Epidemiol Infect 130:507-19. 2003
    ..Our data support the introduction of campaign vaccination in the city in 1998, although higher routine vaccine coverage is required to sustain the impact. The implications of a high prevalence of low-level antibody are discussed...
  12. ncbi request reprint Measles virus strains circulating in Ethiopia in 1998-1999: molecular characterisation using oral fluid samples and identification of a new genotype
    W Nigatu
    Ethiopian Health and Nutrition Research Institute, Addis Ababa, Ethiopia
    J Med Virol 65:373-80. 2001
    ..The degree of divergence from recognised clade D strains suggested that, together with three strains from the United Kingdom, it represents an additional genotype of clade D (GenBank accession numbers AF280800-280807)...
  13. pmc Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months
    F T Cutts
    Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, England
    Bull World Health Organ 72:227-31. 1994
    ..The proportion of cases in children aged > or = 5 years increased from 15.2% to 32.8% in the corresponding periods. The global goals for measles control can be achieved by a single dose of Schwarz vaccine at 9 months of age...
  14. doi request reprint Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia
    M Saaka
    Medical Research Council Laboratories, Fajara, Banjul, Gambia
    Vaccine 26:3719-26. 2008
    ..3 microg/ml (95% CI: 1.0, 5.0). The PCV-9 studied was immunogenic in a Gambian population where it was also found to be efficacious...